News
JOYTON KASKY Foundation donates to orphans
The JOYTON KASKY Foundation has donated food items and clothing worth GHc 6,700 to 34 inmates of the Christian Village Orphanage based in Akwadum, a suburb of Koforidua in the New Juaben North Constituency of the Eastern Region.
The occasion coincided with the third anniversary of the establishment of the Foundation.
Among the items were children’s clothing and footwear, bags of rice, some gallons of vegetable oil, soft drinks,key soap, and bags of sachet water.
Madam Joyce Osei Owusu, Vice President of the Foundation who made the donation on behalf of the group, explained that the gesture was in line with the spirit of Christmas which focused on God’s great gift to humanity through the birth of His only begotten Son, Jesus Christ who ultimately became a sacrifice to save humanity from sin.
She said that act of great love by God continued to motivate JOYTON KASKY to also sacrifice its meagre resources to help alleviate the suffering of vulnerable people like orphans, prisoners, and widows.
Madam Osei Owusu appealed to corporate bodies, churches, philanthropists, and well-meaning people to assist the Foundation to sink a borehole for the orphanage which the institution listed as its priority need.
Madam Edith Ahama, Deputy Administrator of the home, mentioned lack of stationery, school uniforms, and sponsorship for continuing students who passed out of the home and were eager to continue their education as some of the problems they faced.
Receiving the donation, Madam Janet Amankwah, a mother of the home thanked the Foundation for making the Christmas season memorable once again for the children just as the group did last year, too. She promised to ensure fair distribution of the items to the children.
West Africa’s In Vitro Diagnostics (IVD) market currently stands at
US$0.988 billion in 2025 and is set to grow at a 4% CAGR, reaching US$1.388 billion by 2034.
Meanwhile, Africa’s broader medical supplies market is soaring from US$6.5 billion in 2025 to
US$11.18 billion by 2031 at a 10.4% CAGR, with pharmaceutical imports, led by Nigeria’s 60% regional share, are projected to hit US$6.5 billion by 2030, straining cold-chain and logistics
infrastructure.
Yet, amid this rapid expansion, West African hospitals and labs face acute vulnerabilities; 85–99% import dependency on medical equipment and IVDs triggers two-to-four-week delays and severe downtime, foreign exchange shortages drive cost volatility, and over 70% out-of-pocket spending demands urgent efficiencies.
Procurement leaders are responding with a strategic pivot, from lowest-cost bids to service-led sourcing, foreign exchange-hedged contracts, and inventory buffering for reagents, while
regional suppliers already deliver 30–40% faster lead times.
The Hospital Investment & Buyer Leadership Forum, held in collaboration with ABCHealth on 3
June, as part of the World Health Expo (WHX) in Lagos (2-4 June 2026, Landmark Centre), creates a platform for healthcare leaders and vetted suppliers for diagnostics, cold-chain, and digital platforms to connect.
Held under the theme “Advancing hospital growth and innovation:
Investment, strategic partnerships, and technology adoption in West Africa”, attendees can look forward to intelligence on policies like Nigeria’s duty waivers, benchmarking regional
manufacturers, and securing framework agreements for crisis-ready chains, as well as capitalising on the African Continental Free Trade Area (AfCFTA) reforms and donor funding for transparent, tech-enabled systems.
“The Hospital Investment & Buyer Leadership Forum at WHX turns these challenges into opportunities,” Tom Coleman, Portfolio Director – Healthcare, Informa Markets explained.
He noted that“Leaders can secure framework agreements with vetted suppliers, tap AfCFTA and policyincentives like Nigeria’s duty waivers, and build crisis-resilient systems.”
According to a 2026 WHX report titled ‘Building Resilient Healthcare Supply Chains in West Africa, structural shift in West Africa is gaining momentum through localisation, with
Afreximbank’s US$75 million facility spurring the production of devices, vaccines, and biologics alongside Nigeria’s progress from 30% local medicine output in 2024 toward a 70% target by 2030.
The AfCFTA initiative is further accelerating distribution hubs in Nigeria, Ghana, and Côte
d’Ivoire, enabling blended original equipment manufacturer-regional sourcing.
“The Hospital Investment & Buyer Leadership Forum at WHX is a pivotal gathering for healthcare leaders, investors, and suppliers to drive hospital expansion across Nigeria and the region,” Dr. Mories Atoki, CEO, ABCHealth said.
According to him, “We are excited to engage on key topics, from
tools and systems hospitals prioritise for better care, to strategies strengthening facilities and
workforce capabilities, innovative partnership models for resource and technology integration, and financing models enabling sustainable growth. This forum creates unmatched opportunities to forge connections that accelerate service expansion and technology adoption amid West Africa’s healthcare transformation.”
WHX brings together more than 500 exhibitors showcasing cutting-edge medical solutions, over 8,000 professional visitors and 30 world-renowned speakers sharing insights that matter across three dynamic parter-led forums, creating opportunities for market expansion and strategic partnerships.
Sectors represented at the exhibition include medical devices and equipment, disposables and consumer goods, orthopaedics and physiotherapy, imaging and diagnostics, healthcare and general services, healthcare infrastructure, wellness and prevention, laboratory,
as well as IT and solutions.
New features at WHX include an integrated Lab Zone, showcasing diagnostics, equipment, and
consumables with live demonstrations, and a networking lounge for business connections, hands-on workshops, expert insights and buyer matchmaking to drive commercial outcomes.
The WHX portfolio includes three key healthcare events in Africa, held in Johannesburg, Nairobi,
and Lagos. These events form a unified platform that connects global brands with regional
distributors.
Healthcare professionals, suppliers, and investors are encouraged to register to attend WHX,
apply to exhibit, and explore its rich conference learning and networking opportunities as part of
Africa’s healthcare future.
The National Health Insurance Authority (NHIA) has temporarily suspended three pharmacies from providing services under the National Health Insurance Scheme (NHIS) over suspected irregularities in claims and service transactions.
The affected pharmacies are Deldem Pharma Limited, Paramedica Pharmacy and Desh Chemist.
According to a public notice issued by the NHIA on May 14, the suspension took immediate effect.
The Authority explained that a routine claims verification exercise uncovered what it described as “material irregularities” linked to claims and service transactions involving the three facilities.
It stated that the findings raised reasonable suspicion of fraud and abuse under the NHIS Provider Service Agreement.
As part of the suspension, the pharmacies are not allowed to provide healthcare services or dispense medicines under the NHIS until further notice.
The NHIA advised NHIS members who need pharmaceutical services to seek care from other accredited providers across the country.
In the statement signed by the Chief Executive of the NHIA, Victor Asare Bampoe, the Authority warned all credentialed healthcare providers against engaging in fraudulent practices that could threaten the sustainability of the scheme.
It stressed that healthcare providers who defraud or attempt to defraud the NHIS commit an offence punishable by a fine, imprisonment of up to 10 years, or both upon conviction.
The NHIA reaffirmed its commitment to transparency, accountability and the proper use of public funds in delivering quality healthcare services to Ghanaians.
By: Jacob Aggrey
